FUKUI, Japan - A Japanese drugmaker was ordered Tuesday to suspend its business for 116 days, the longest such order ever imposed on a pharmaceutical company in the country, after systematically making up fictitious production records on nearly 80 percent of its 500 products.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
